RespIn 11 Bronchial Airway Clearance System is a "Focused Pulse" High Frequency Chest Wall Oscillation (HFCWO) device that maximizes the use of modern technologies and materials to produce a more comfortable, flexible and effective therapy delivery system.
Through the use of modern technologies and materials, these systems produce a high quality therapy without pain or irritation associated with other "Vest Therapy Systems". Respin 11 uses a patented system of valves, electronic control and targeted pressure pistons to deliver pulsations directly to targeted areas of the patient's thorax - exactly where they are needed.
RespInnovation SAS has conceptualized, designed and realized its RespIn 11 Bronchial Airway Clearance System as a 2nd generation ‘focused pulse’ High Frequency Chest Wall Oscillation (HFCWO) device that maximizes the use of modern technologies and materials to produce a more comfortable, flexible and effective therapy delivery system. The RespIn 11 uses an innovative patented system of ‘focused pulse’ technology incorporating a system of proprietary valves, pressure pistons and electronic controls which deliver therapeutic pulsations directly to targeted areas of the patient’s thorax - exactly where most required and most beneficial in the treating clinician’s view.
RespIn 11 benefits from a totally new innovative approach to the 30 year old concept of High Frequency Chest Wall Oscillation/Chest Compression therapy and makes maximum use of modern technologies and materials to:
• Delivers therapeutic ‘focused pulse’ therapy direct to selected parts of the patient thorax creating a more profound and efficient resonance in the bronchial airways which is delivered in a comfortable ‘massage like’ therapy.
• Flexibility of RespIn 11’s ‘focused pulse’ technology also gives treating clinicians greatly increased control and flexibility of therapy to best meet the needs of each individual patient and clinical condition.
• Very low background pressure - The RespIn 11 patented system of focused pulsations cycle from empty to full up to 20 times per second yet operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for
• No negative physiological side effects - as a beneficial side effect of its low operating pressure of RespIn 11’s ‘focused pulse’ technology, it has no negative side effects to the patient’s physiological parameters, e.g. blood pressure and heart rate, and the RespIn 11 can therefore be safely used with a much wider range of patients and clinical conditions than existing Chest Compression devices.
One of the greatest joys of this season for all RespInnovation's team is the opportunity to say thank you to all our customers & partners and to wish you the very best for the New Year 2018!